Physician profile
Sophia Frontus
NPI 1518338821
$52,318.17
in general payments reported to CMS, 2019-2025
10 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $29K · 2023: $4,004 · 2024: $1,989 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $1,839 · Travel and Lodging: $1,720 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,760.00 |
| Food and Beverage | $1,839.22 |
| Travel and Lodging | $1,719.91 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $51,267.20 | 2021-2025 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals Lp | $282.13 | 2022-2025 | Lynparza |
| Genmab U.S., INC. | $221.47 | 2021-2025 | Tivdak |
| Merck Sharp & Dohme LLC | $219.62 | 2021-2025 | Keytruda, Lynparza |
| Myriad Genetic Laboratories, INC. | $92.33 | 2021-2022 | |
| Eisai INC. | $71.64 | 2021-2022 | |
| Clovis Oncology, INC. | $57.09 | 2021-2022 | |
| Caris Mpi, INC. | $42.64 | 2025 | Mi Cancer Seek |
| Genzyme Corporation | $34.81 | 2022 | |
| Daiichi Sankyo INC. | $29.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Frontus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.